4 Signs the Pharmacy Benefits Market is in Transition and What Advisors Can Do
The pharmacy benefits market is more unsettled than it's been in years and your clients feel it. Costs keep climbing....
RxBenefits's Posts
The GLP-1 Coverage Strategy Employers May be Overlooking
When Starbucks announced it would stop covering GLP-1 medications for weight loss, benefits leaders recognized the pressure behind that decision....
Five Differentiators That Matter in a Transparent PBM
Every transparent pharmacy benefits manager (PBM) claims to save your clients money. With a pass-through contract, the vendor earns a...
PBM Contract Terms Decoded: A Plain-Language Glossary for Benefits Advisors
Two pharmacy benefits manager (PBM) proposals land on your desk. Both promise deep discounts. Both quote strong rebates. On the...
4 Reasons the Biosimilar Boom Could Save Your Clients $232 Billion
The next decade will reshape specialty drug spending, and the opportunity is enormous. As more than 100 biologic drugs lose...
PBM Reform at Midyear 2026: Litigation and Legislative Updates for Self-Insured Plan Sponsors
The momentum behind pharmacy benefits management (PBM) reform has not slowed in 2026. As the year passes its midpoint, federal enforcement,...
10 Most Expensive Drugs in the U.S.: 2026 Edition
Brand-name specialty drugs dominate the list of the most expensive medications in the U.S. These treatments address chronic, rare, and...
RxBenefits Receives Two Honorable Mentions at Ragan PR Daily Marketing Award
Recognition matters most when it reflects work that helps people make better decisions. That is why we are proud to...
5 Questions Benefits Advisors Should Ask Before Recommending a PBM Switch
You face constant pressure to manage your clients’ pharmacy benefits costs. And so, when pharmacy benefits management (PBM) models offer fresh savings promises, they easily capture...
